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Abstract: Condensation of a pyridyl-2-carbaldehyde derivative with 
2-(bromoethyl)amine hydrobromide affords tetracyclic pyrido[1,2-
a]pyrido[1',2':3,4]imidazo-[2,1-c]-6,7-dihydropyrazinium dications in 
excellent yields. Crystal structures and NOE data demonstrate the 
helical character of the dications, the dihedral angles between the 
two pyrido groups ranging from 28-45°. An intermediate in the 
synthesis was also characterized. A much brighter emission 
compared to literature helicenes has been found, with quantum 
yields as high as 60% in the range of 460-600 nm. Preliminary 
cytotoxicity studies against HT-29 cancer cells demonstrated 
moderate-to-good activity, with IC50 values 12-30x that of cisplatin. 
Helical poly-aromatic compounds (helicenes) are of intense 
current interest.[1-3] Apart from the synthetic challenges involved 
in preparing and resolving such compounds,[1,2,4] they are useful 
auxiliary groups for asymmetric reactions and chiral catalysis.[3,5] 
Helicenes and their derivatives can be chiral components in self-
assembly systems[1,3,6] and macromolecular materials,[3,7] while 
many helicenes are fluorescent, with a chiral emission when 
optically pure. Moreover, helicenes containing quinone,[4] 
pyridinium[8–10] or thieno[11] fragments, or an appended metal 
ion,[12] are redox-active and therefore switchable. This has led to 
the development of organic light-emitting diodes (OLEDs) and 
other chiroptical devices based on helicene fluorophores.[3,13] 
The synthesis of pyrido[1,2-a]pyrido[1',2':3,4]imidazo-[2,1-c]-
6,7-dihydropyrazinium dibromide (1Br2, Scheme 1) by an acid-
catalysed reaction of pyridine-2-carboxaldehyde with (2-
bromoethyl)amine was first reported by Glover et al. in 1969.[14] 
They proposed a mechanism for the transformation,[15] and 
described the reactivity of 1Br2 towards basic hydrolysis and 
hydrogenation. We fortuitously prepared 1Br2 during our studies 
of heterocyclic chelate ligands for transition ions,[16] and report 
now a more detailed study of this [4]-helical heterocycle and its 
derivatives. While no more detailed structural or physical data 
from 1Br2 have been reported so far, we note its relationship to 
diquat helicene derivatives,[8–10] some of which exhibit 
particularly favorable chiroptical properties.[9] 
 
Scheme 1. Compounds referred to in this work. 
As previously described,[14] reaction of pyridine-2-
carboxaldehyde with (2-bromoethyl)amine hydrobromide in 
equimolar ratios in THF at room temperature affords 1Br2 as a 
brown precipitate in good yield. The freshly prepared precipitate 
is analytically pure, but can be recrystallized from ethanol/water 
to afford monohydrate crystals 1Br2∙H2O. Treatment of aqueous 
1Br2 with excess NH4PF6 precipitates 1[PF6]2, which is more 
soluble in organic solvents. Repeating the procedure using 6-
methylpyridine-2-carboxaldehyde, quinoline-2-carboxaldehyde 
or 6-(2-thienyl)-pyridine-2-carboxaldehyde afforded the 
disubstituted derivatives 3[PF6]2, 5[PF6]2 and 6[PF6]2 
respectively. More forcing conditions were needed to push these 
reactions to completion, however, and the 2-(2-bromoethyl)-3-
(pyridin-2-yl)imidazo-[1,5-a]-pyridinium intermediates 2[PF6] and 
4[PF6] were also isolated from such reactions performed at room 
temperature. While 2[PF6] was obtained as a pure solid, 4[PF6] 
was always contaminated with 5[PF6]2 and was purified for 
characterization by a Pasteur separation. Hence, a wider 
physicochemical study of that compound was not undertaken. 
Heating 2[PF6] and 4[PF6] in DMF at 100 °C caused their 
stoichiometric conversion to 3[PF6]2 and 5[PF6]2 by 
1H NMR.[15] 
Single crystal X-ray structure determinations of 1Br2∙H2O; 
3[PF6]2, 4[PF6], 5[PF6]2 and 6[PF6]2∙CH3OH confirmed their 
respective connectivity (Fig. 1). The metric parameters within the 
tetracyclic framework are consistent with the tautomeric 
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structures shown, with clear single/double bond length 
alternation in the imidazo[1,5-a]pyridinium fragments.[17] The 
tetracyclic dications all adopt helical conformations with the 
degree of helicity, as measured by the dihedral angle between 
the two pyrido rings (), being: 
12+ [ = 27.64(6)°] < 32+ [36.39(4)°] ≈  
62+ [37.19(8)°] < 52+ [45.23(4)°] 
This non-planarity reflects an intramolecular contact between the 
H atoms bound to pyridinium C3 and imidazo[1,5-a]pyridinium 
C5 (C(5) and C(14) in Fig. 1), which are 2.19 Å apart in 
1Br2∙H2O.
[18] This steric repulsion is exacerbated in 32+, 52+ and 
62+, which have substituents at the imidazo[1,5-a]pyridinium C5 
position. Only 3[PF6]2 crystallizes as optically pure helical 
molecular crystals, in a chiral space group. The crystal 
examined has P () helicity, but equal numbers of P- and M-
helical crystals are present in the bulk sample. The other three 
dications form racemate crystals, in centrosymmetric space 
groups. Most of the helicity is generated by rotation about the 
C(6)−C(7) bond in the dihydropyrazinium ring (Fig. 1), although 
a sterically-induced bending of the conjugated imidazo[1,5-
a]pyridinium fragment is also evident, particularly in 3[PF6]2. The 
conformational strain implied by this increased helicity accounts 
for our isolation of 2[PF6] and 4[PF6], and the need for forcing 
conditions to complete the synthesis of 3[PF6]2 and 5[PF6]2. 
Consistent with that, the quinolyl and imidazo[1,5-a]quinolinium 
groups in 4[PF6] are close to perpendicular [ = 78.27(3)°], 
reflecting the relief of steric congestion between these groups by 
free rotation about the C(5)−C(6) bond.[17] The retention of these 
helical conformations in CD3CN solution was confirmed by 
NOESY analyses, which demonstrated strong NOE 
enhancements between the pyridinium H3 atom and either the  
imidazo[1,5-a]pyridinium H5 atom (1[PF6]2), or the methyl group 
at that position (3[PF6]2).
[17] 
 
Figure 1. Top: view of the 1
2+
 dication in the crystal structure of 1Br2∙H2O. 
Thermal displacement ellipsoids are set at 50 %. Bottom: space-filling view of 
1
2+
, showing the intramolecular steric clash that gives rise to the helicity. The 
view is along the C(7)–N(8) bond.
[17]
  
Polyaromatic dyes can be DNA intercalators, which bind 
between stacked base pairs in the DNA double helix.[19] Since 
DNA intercalators can inhibit nucleic acid synthesis in vivo and 
are therefore cytotoxic,[20] a preliminary cytotoxicity study was 
performed by screening 1Br2∙H2O, 1[PF6]2, 2[PF6] and 5[PF6]2 
against HT-29 (human colon adenocarcinoma) cancer cells. The 
salts 1Br2 and 1[PF6]2 exhibit moderate cytotoxicities against 
this cell line, compared to a cisplatin standard measured under 
the same conditions (Table 1). Their identical IC50 values imply 
that the counterions Br− and PF6
− have no influence on cell 
viability. The other two compounds show improved IC50 values, 
of ca. 10x higher than cisplatin. This might be attributed to 
different factors in the two compounds. First is the 
conformational flexibility of 2+, whose pyridinium and imidazo-
[1,5-a]pyridinium groups can rotate freely with respect to each 
other. That will allow 2+ to adjust its conformation in response to 
the steric environment about the DNA nucleobase stacks. 
Second, is the extended conjugation of the quinolinium groups in 
5[PF6]2, which increases its hydrophobicity and promotes strong 
intercalative – interactions with the DNA bases. 
Table 1. Cytotoxicity data for compounds in this work, and a cisplatin 
standard, against the HT-29 cancer cell line. 
Compound IC50 (M) Compound IC50 (M) 
1Br2∙H2O 107±3 2[PF6] 64±1 
1[PF6]2 110±2 5[PF6]2 44±1 
  Cisplatin 3.6±0.2 
 
Aside from their biological activity, these compounds also 
demonstrate interesting photophysical and electrochemical 
properties (Table 2, Fig. 2).[8,10] Assignment of their UV/vis 
absorption bands is hindered by limited literature precedent.[8,9] 
However, based on their energies, we have tentatively ascribed 
the high energy bands (270-350 nm) of these compounds as 
typical –* localized transitions, while the lower energy bands 
are plausibly charge transfer (CT) transitions between the 
charged pyridinium and imidazolium rings. 
 
Figure 2. UV/vis spectra of 1Br2 (□), 1[PF6]2 (), 2[PF6] (), 3[PF6]2 (), 
5[PF6]2 () and 6[PF6]2 () in MeCN at 298 K. 
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Table 2. Photophysical
[a]
 and electrochemical
[b]
 data for the compounds in this work. 
Compound 1Br2 1[PF6]2 2[PF6] 3[PF6]2 5[PF6]2 6[PF6]2 
max [nm]  
(max [10
3
 M
−1
cm
−1
]) 
303 (3.27) 
315 (3.47) 
329 sh  
384 sh  
406 (16.4) 
303 (3.34)  
315 (3.34)  
329 sh  
387 sh  
406 (21.5) 
291 (13.2)  
299 (13.2)  
312 sh  
326 sh  
415 (0.69) 
275 (5.11)  
315 (4.16) 
331 sh  
395 sh  
415 (23.4) 
284 (23.0)  
313 (9.62)  
329 sh  
439 sh  
464 (27.3) 
297 (12.7) 
348 (11.8) 
439 (12.3) 
em [nm] 467 469 476 481 545 599 
PL [%] 33 42 29 22 60 0.2 
e [ns] 3.84 3.99 3.98 4.25 6.78 6.60 
E
1
½ [V] (Ep [mV]) −0.61 (112) −0.61 (101) −1.26
[c] 
−0.74
[c] 
−0.22
[c] 
−0.59
[c] 
E
2
½ [V] (Ep [mV]) −1.22 (82) −1.26 (79)  −1.22 (60) −0.80
[c]
 −1.09
[c]
 
[a]
In deaerated acetonitrile at 298 K. Quinine sulfate was used as the reference (ΦPL = 54.6% in 0.5 M H2SO4 at 298 K)
[22]
 in all cases except 
for 6[PF6]2, for which [Ru(bpy)3][PF6]2 was used (ΦPL = 9.5% in deaerated acetonitrile at 298 K).
[23]
 
[b]
Measurements were performed at 100 
mV s
−1
 in deaerated MeCN solution at 298 K using Fc/Fc
+
 as an internal standard, and are referenced with respect to SCE (Fc/Fc
+ 
= 0.38 V 
in MeCN).
 [c]
Irreversible process, Epc value quoted.
 
 
As might be expected, changing the counterion from 1Br2 to 
1[PF6]2 causes very little change in the absorption spectra. At 
high energies, there are multiple bands or shoulders (303, 315 
and 329 nm), which demonstrate virtually identical absorptivities 
regardless of the counter ion. Similarly, at lower energies (384-
387 and 406 nm) the form of the spectra is unchanged, although 
the absorptivity observed for 1Br2 in this part of the spectrum is 
slightly lower than for 1[PF6]2. The methyl substituents in 3[PF6]2 
do not appreciably alter the spectra compared to 1[PF6]2, with 
only the CT band undergoing a small 534 cm–1 red-shift with a 
moderate increase in absorptivity. This red-shift, invoked by the 
electron-donating nature of the methyl groups, points to 
localisation of the HOMO on regions of the molecule adjacent to 
the charged nitrogen atoms. This is supported by the greater 
red-shift of the CT band (1851 cm–1 compared to 1[PF6]2) 
induced by the more electron-donating 2-thienyl groups of 
6[PF6]2. The extended aromaticity in 5[PF6]2 pushes the CT 
band even more to the red, by 3079 cm−1 compared to 1[PF6]2. 
While the CT bands vary significantly based on the 
aromaticity and substituents of the dihydrohelicenes, the high 
energy bands are largely unaffected. The only noticeable 
changes come with 5[PF6]2, whose extended aromaticity 
increases the overall absorptivity, and with 6[PF6]2 which 
demonstrates an additional π-π* transition at 348 nm associated 
with the 2-thienyl units. 
The ring-opened intermediate 2[PF6] has no enforced 
coplanarity of the pyridyl and imidazolyl rings. As a result, the 
only pronounced bands are the high energy –* transitions, 
localized on the individual pyridyl and imidazolyl rings, which 
show reasonably large absorptivities in the region of ~13000 M–
1cm–1; by comparison, the low energy pyridyl-imidazolyl CT 
transition is poorly absorbing (<700 M–1 cm–1) since there is poor 
orbital overlap between the two mutually orthogonal 
heterocycles. Upon ring closure to generate 3[PF6]2, the 
absorptivity drastically increases, indicating significantly 
improved orbital overlap facilitating the CT transition. 
Compounds 1Br2, 1[PF6]2, 2[PF6] and 3[PF6]2 are deep blue 
emitters, while 5[PF6]2 and 6[PF6]2 are green-yellow and orange 
in color, respectively (Table 2, Fig. 3). The emission spectra of 
1Br2 and 1[PF6]2 overlap, indicating that the counterion plays no 
role in the emission process. The methyl groups in 3[PF6]2 
induce a small 532 cm–1 red-shift in em compared to 1[PF6]2, 
supporting the assertion that they are primarily modulating the 
electronics of the HOMO; a very large red-shift of 4629 cm–1 
observed for 6[PF6]2, bearing electron donating 2-thienyl 
substituents, is also consistent with this assignment. Extending 
the aromaticity in 5[PF6]2 also red-shifts emission. Interestingly, 
despite its only bearing one charged center, 2[PF6] 
demonstrates similar photophysical properties to 3[PF6]2, with a 
blue-shift of only 218 cm–1. All the compounds show emission 
lifetimes in the nanosecond regime, which indicate fluorescence. 
Compounds 1Br2, 1[PF6]2, 2[PF6] and 3[PF6] are the shortest, in 
the range of 3.84-4.25 ns, while 5[PF6]2 and 6[PF6] are 6.60-
6.78 ns. 
 
Figure 3. Normalized emission spectra of 1Br2 (□), 1[PF6]2 (), 2[PF6] (), 
3[PF6]2 (), 5[PF6]2 () and 6[PF6]2 () in deaerated MeCN at 298 K.  
Although a number of emissive helical cationic-type 
molecules have been reported,[8,10,21] their ΦPL values were not 
usually determined which makes comparisons difficult. However, 
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Clennan and co-workers recently reported a dicationic helicene, 
which contained two N-methylated quarternary ammonium 
centers, that emitted with ΦPL = 6.6 %.
[10] In contrast, the 
compounds in this work, whose quarternary N atom is contained 
within an aliphatic heterocycle, are much brighter with ΦPL as 
high as 60% in the case of 5[PF6]2. Here the brightness of the 
emission is enhanced through rigidification of the 
dihydrohelicene framework by the quinolinyl units. Only 6[PF6]2 
was found to be poorly emissive, which we ascribe to a “loose 
bolt” effect resulting from the large 2-thienyl units. 
Finally, the relevant electrochemical data are summarized in 
Table 2.[17] All compounds except for 2[PF6] show two quasi-
reversible or irreversible one-electron reduction steps, as has 
been frequently observed for other dicationic heliquats.[9,10] 
2[PF6] only shows a single poorly resolved reduction wave. No 
oxidation waves were observed except in the case of 1Br2, 
which was attributed to oxidation of bromide. 
The reduction waves of 1Br2 and 1[PF6]2 are virtually 
identical, as expected. Surprisingly, in spite of the small red-shift 
in absorption and emission observed for 3[PF6]2, the first 
reduction wave is 0.11 V lower than 1[PF6]2. The Epc values 
mirror this, with the value appearing at −0.57 V for 1Br2 and 
1[PF6]2, but at −0.65 V for 3[PF6]2. However, the second wave is 
largely unchanged. 5[PF6]2, by virtue of its extended aromaticity, 
sees a large anodic shift in both reduction waves. In comparison, 
6[PF6]2 undergoes a more modest change, consistent with the 
suggestion that the 2-thienyl groups are largely modulating the 
electronics of the HOMO. Interestingly, the reduction potential 
for 2[PF6] largely matches those of 1Br2, 1[PF6]2 and 3[PF6]2. 
This suggests that the second reduction process observed for 
the dicationic species is attributable to reduction of the 
imidazolium moiety, and thus the first wave – which is not 
observed for 2[PF6] – can be ascribed to reduction of the 
pyridinium moiety. 
In conclusion, a one-pot synthesis of a family of helical 
dications has been reported. Solutions of 1[PF6]2-5[PF6]2 are 
highly fluorescent, with emissions ranging from the blue to 
orange. The emission from 6[PF6]2 was significantly weaker, 
which was ascribed to increased non-radiative decay due to the 
“loose bolt” effect of the pendant 2-thienyl units. 
Experimental Section 
Synthetic procedures and characterization data for all the compounds in 
this work, as well as details of the instrumentation and procedures used 
for the spectroscopic and electrochemical measurements and the crystal 
structure determinations, are given in the Supporting Information.[17] 
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